4.7 Article

Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer

Chan-Ping You et al.

Summary: Biomarkers, such as estrogen receptor alpha(ER alpha), human epidermal growth factor receptor 2 (HER2), and androgen receptor (AR), have been widely used in breast cancer diagnosis, prognosis, and prediction. AR serves different roles in different breast cancer subtypes, acting as a tumor suppressor in ER+ breast cancers but a tumor promoter in ER- breast cancers. AR expression status can also predict the response to hormonal therapy and chemotherapy. Therefore, AR has the potential to be a useful biomarker in breast cancer.

BIOMOLECULES (2022)

Article Behavioral Sciences

The scholar's best friend: research trends in dog cognitive and behavioral studies

Massimo Aria et al.

Summary: This study analyzed the publication trend of articles on dog cognition and behavior over the past 34 years, revealing a significant increase in scientific publications on dogs since 2005. An in-depth bibliometric analysis was conducted on dog cognitive and behavioral studies, which supported the perception that dogs are attracting more interest from scholars and contributing to interdisciplinary collaborations and future research in the field.

ANIMAL COGNITION (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, General & Internal

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

Wei Cao et al.

Summary: This study summarized the recent changing profiles of cancer burden worldwide and in China, revealing that breast cancer became the most diagnosed cancer globally in 2020. China accounted for 24% of newly diagnosed cases and 30% of cancer-related deaths worldwide in 2020, with a high cancer mortality rate.

CHINESE MEDICAL JOURNAL (2021)

Review Multidisciplinary Sciences

Epigenetic mechanisms in breast cancer therapy and resistance

Liliana Garcia-Martinez et al.

Summary: The majority of breast cancers express the estrogen receptor and endocrine therapy has been the mainstay for hormone-responsive breast cancer treatment. Recent studies have shown the importance of the epigenome in determining hormone therapy response and how targeting epigenetic factors can help overcome clinical resistance. Understanding epigenetic mechanisms regulating ER+ breast cancer and endocrine therapy resistance is crucial for improving targeted therapies for this type of cancer.

NATURE COMMUNICATIONS (2021)

Article Oncology

Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020

Haibo Qiu et al.

Summary: Cancer is a major cause of death and economic burden in China, with lower incidence but higher mortality and DALY rates compared to the US and UK. The cancer spectrum in China is changing, with increasing burden of certain cancers and a shift towards patterns seen in developed countries.

CANCER COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights

Aristomenis Anestis et al.

MOLECULES (2020)

Review Chemistry, Medicinal

Aromatase inhibitors: Role in postmenopausal breast cancer

Rajeev Kharb et al.

ARCHIV DER PHARMAZIE (2020)

Review Oncology

Overcoming Endocrine Resistance in Breast Cancer

Ariella B. Hanker et al.

CANCER CELL (2020)

Review Endocrinology & Metabolism

Androgen Receptor in Breast Cancer: From Bench to Bedside

Mengyao Chen et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Oncology

Male breast cancer: a disease distinct from female breast cancer

Ayca Gucalp et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Review Medical Laboratory Technology

Androgen receptor: A promising therapeutic target in breast cancer

Stella K. Vasiliou et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)

Review Pharmacology & Pharmacy

Consideration of breast cancer subtype in targeting the androgen receptor

Clasina M. Venema et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Review Oncology

Androgen receptor plasticity and its implications for prostate cancer therapy

Oliver Snow et al.

CANCER TREATMENT REVIEWS (2019)

Article Multidisciplinary Sciences

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Saif Aldeen S. AlRyalat et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)

Review Biochemistry & Molecular Biology

Recent Advances in Prostate Cancer Treatment and Drug Discovery

Ekaterina Nevedomskaya et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Oncology

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer

Tiffany A. Traina et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Review Urology & Nephrology

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

E. David Crawford et al.

JOURNAL OF UROLOGY (2018)

Review Cell Biology

Estrogen and progesterone signalling in the normal breast and its implications for cancer development

Heidi N. Hilton et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Review Pharmacology & Pharmacy

Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment

Hitisha K. Patel et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Biotechnology & Applied Microbiology

Induced protein degradation: an emerging drug discovery paradigm

Ashton C. Lai et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Computer Science, Interdisciplinary Applications

bibliometrix: An R-tool for comprehensive science mapping analysis

Massimo Aria et al.

JOURNAL OF INFORMETRICS (2017)

Article Oncology

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort

Karin Elebro et al.

BREAST CANCER RESEARCH AND TREATMENT (2017)

Article Oncology

Targeting the androgen receptor in triple-negative breast cancer

Ayca Gucalp et al.

CURRENT PROBLEMS IN CANCER (2016)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Review Oncology

Androgen receptor and antiandrogen therapy in male breast cancer

Luigi Di Lauro et al.

CANCER LETTERS (2015)

Article Anatomy & Morphology

How to judge a book by its cover? How useful are bibliometric indices for the evaluation of scientific quality or scientific productivity?

Oliver von Bohlen Und Halbach

ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2011)

Review Chemistry, Multidisciplinary

Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds

Fatiah Issa et al.

CHEMICAL REVIEWS (2011)

Article Biochemistry & Molecular Biology

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

Jessica L. L. Robinson et al.

EMBO JOURNAL (2011)

Review Cell Biology

Pioneer transcription factors: establishing competence for gene expression

Kenneth S. Zaret et al.

GENES & DEVELOPMENT (2011)

Article Medicine, Research & Experimental

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Oncology

Triple-Negative Breast Cancer: An Unmet Medical Need

Clifford A. Hudis et al.

ONCOLOGIST (2011)

Article Oncology

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

Francesca De Amicis et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Computer Science, Interdisciplinary Applications

Software survey: VOSviewer, a computer program for bibliometric mapping

Nees Jan van Eck et al.

SCIENTOMETRICS (2010)

Article Computer Science, Information Systems

CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature

CM Chen

JOURNAL OF THE AMERICAN SOCIETY FOR INFORMATION SCIENCE AND TECHNOLOGY (2006)

Article Multidisciplinary Sciences

Molecular portraits of human breast tumours

CM Perou et al.

NATURE (2000)